Transduced mesenchymal stem cells
US5591625A · kind A · utility
234Cited by
14References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 1993 |
| Grant date | Jan 7, 1997 |
| Priority date | — |
| Expiry date | Nov 24, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/13043
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Genetically engineered human stem cells that carry within them genes of interest particularly for the expression of physiologically or pharmacologically active proteins or for use in gene therapy. In addition to correction of genetic disorders, is the ability to introduce, in a targeted manner, additional copies of essential genes to allow expression in proliferating, nondifferentiating cells of certain gene products. These genes can be, for example, hormones matrix proteins, cytokines, adhesion molecules, detoxification enzymes and "rebuilding" proteins important in tissue repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.